200 related articles for article (PubMed ID: 4710038)
21. [Immune reactivity in colorectal cancer--clinical value from a surgical viewpoint].
Muhrer KH; Schwemmle K; Filler D; Kahle M
Chirurg; 1982 Feb; 53(2):112-6. PubMed ID: 7075339
[TBL] [Abstract][Full Text] [Related]
22. The LMI test in colon, breast and lung cancer long survivors.
Fazio M; Calabrese F; Coluccia C; Giacomasso S; Casadio C; Mancuso M; Negri L; Mastromatteo V
Panminerva Med; 1992; 34(2):60-4. PubMed ID: 1408329
[TBL] [Abstract][Full Text] [Related]
23. [Immunoreactivity in colorectal cancer. Approaches for an immunologic diagnosis?].
Muhrer KH; Kahle M; Pasurka B
Schweiz Med Wochenschr; 1983 Apr; 113(15):546-7. PubMed ID: 6857208
[TBL] [Abstract][Full Text] [Related]
24. Detection of carcinoembryonic antigen in the media of cultures of carcinomatous cells of digestive-system origin.
Laing CA; Heppner GH; Kopp LE; Calabresi P
J Natl Cancer Inst; 1972 Jun; 48(6):1909-11. PubMed ID: 5066473
[No Abstract] [Full Text] [Related]
25. Cell-mediated and serum blocking reactivity to tumor antigens in patients with malignant melanoma.
Heppner GH; Stolbach L; Byrne M; Cummings FJ; McDonough E; Calabresi P
Int J Cancer; 1973 Mar; 11(2):245-60. PubMed ID: 4790694
[No Abstract] [Full Text] [Related]
26. Tumor-specific cellular immunity.
Cohen AM; Burdick JF; Ketcham AS
J Surg Res; 1971 Aug; 11(8):421-31. PubMed ID: 4936302
[No Abstract] [Full Text] [Related]
27. Assessment of cell-mediated immunity to human tumor-associated antigens.
Baldwin RW; Embeton MJ
Int Rev Exp Pathol; 1977; 17():49-95. PubMed ID: 849883
[No Abstract] [Full Text] [Related]
28. [Immunological exploration of cancer patients. II. Tumoral immunity].
Cappelaere P; Demaille A; Adenis L
Lille Med; 1973 Feb; 18(2):179-201. PubMed ID: 4581842
[No Abstract] [Full Text] [Related]
29. Cell- and antibody-mediated immune reactions of patients to cultured cells of breast carcinoma.
Sinkovics JG; Reeves WJ; Cabiness JR
J Natl Cancer Inst; 1972 Apr; 48(4):1145-9. PubMed ID: 5023675
[No Abstract] [Full Text] [Related]
30. Tuberculin reaction in cancer patients, "Mantoux release," and lymphosuppressive-stimulatory factors.
Steward AM
J Natl Cancer Inst; 1973 Mar; 50(3):625-32. PubMed ID: 4708150
[No Abstract] [Full Text] [Related]
31. Cellular immunity to human tumor-associated antigens. A review.
Herberman RB
Isr J Med Sci; 1973 Mar; 9(3):300-7. PubMed ID: 4575654
[No Abstract] [Full Text] [Related]
32. [The natural killer blood count in patients with breast, colon and rectal cancers].
Dryzhak VI; Iaremenko AV; Khramtsova NS
Vopr Onkol; 1989; 35(5):585-9. PubMed ID: 2741429
[TBL] [Abstract][Full Text] [Related]
33. Potentiation of human cell-mediated and humoral immunity by low-dose cyclophosphamide.
Berd D; Maguire HC; Mastrangelo MJ
Cancer Res; 1984 Nov; 44(11):5439-43. PubMed ID: 6488195
[TBL] [Abstract][Full Text] [Related]
34. DNCB sensitivity in cancer patients. A review based on sequential testing in 430 patients.
Bolton PM
Clin Oncol; 1975 Mar; 1(1):59-69. PubMed ID: 1106933
[No Abstract] [Full Text] [Related]
35. In vitro demonstration of cell-mediated immunity against human renal carcinoma assessed by the leukocyte migration assay.
Pappas A; Schwarze G
Z Immunitatsforsch Exp Klin Immunol; 1974 Nov; 148(2):142-50. PubMed ID: 4143237
[No Abstract] [Full Text] [Related]
36. Inhibition of migration of human autogenous and allogeneic leukocytes by extracts of patients' cancers.
Wolberg WH
Cancer Res; 1971 Jun; 31(6):798-802. PubMed ID: 4326036
[No Abstract] [Full Text] [Related]
37. Her-2/neu-derived peptides are tumor-associated antigens expressed by human renal cell and colon carcinoma lines and are recognized by in vitro induced specific cytotoxic T lymphocytes.
Brossart P; Stuhler G; Flad T; Stevanovic S; Rammensee HG; Kanz L; Brugger W
Cancer Res; 1998 Feb; 58(4):732-6. PubMed ID: 9485028
[TBL] [Abstract][Full Text] [Related]
38. Lymphocyte stimulation by phytohemagglutinin and tumor cells of malignant effusions.
Robinson E; Sher S; Mekori T
Cancer Res; 1974 Jul; 34(7):1548-51. PubMed ID: 4275697
[No Abstract] [Full Text] [Related]
39. Antitumor activity in melanoma and anti-self responses in a phase I trial with the anti-cytotoxic T lymphocyte-associated antigen 4 monoclonal antibody CP-675,206.
Ribas A; Camacho LH; Lopez-Berestein G; Pavlov D; Bulanhagui CA; Millham R; Comin-Anduix B; Reuben JM; Seja E; Parker CA; Sharma A; Glaspy JA; Gomez-Navarro J
J Clin Oncol; 2005 Dec; 23(35):8968-77. PubMed ID: 16204013
[TBL] [Abstract][Full Text] [Related]
40. Enhancement of lymphocyte-mediated cytotoxicity after tumor resection in patients with colorectal cancer.
Waller CA; Gill PG; MacLennan IC
J Natl Cancer Inst; 1980 Aug; 65(2):223-30. PubMed ID: 6931244
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
